Healthtech Startups

CARMAT develops Aeson, a total artificial heart that replaces both ventricles to treat patients with end-stage biventricular heart failure. The device is commercially available as a bridge to transplant in the European Union and countries recognizing CE marking, and is under an Early Feasibility Study in the United States.

1 investor

Carmina de Young designs and manufactures garments and personal protective equipment, including AAMI Level 1-3 isolation gowns, coveralls, and scrubs, in both disposable and reusable forms. It supplies the Canadian federal government, hospitals, and emergency services personnel such as firefighters, police, and paramedics.

1 investor

CarobWay develops clean-label food ingredients derived from carob, using a zero-waste process to turn the crop into products for the food industry. The company positions itself around sustainable, science-backed food solutions.

1 investor

Carocell Bio develops peptide-based anti-inflammatory therapeutics, including its lead peptide JEL0305, that inhibit the intracellular MAPK (p38) inflammatory pathway and are combined with a nanoparticle delivery technology for topical application to the skin. It targets inflammatory conditions such as eczema (atopic dermatitis) and inflammation-related skin ageing.

1 investor

CaroGen Corporation develops immunotherapies for cancer and infectious diseases based on an enveloped self-amplifying mRNA (virus-like vesicle) platform, with lead candidates including CARG-2020 for ovarian and other cancers and CARG-201 for hepatitis B. The company works with academic and government partners such as Wayne State University, UConn Health, and NIH/NIAID.

1 investor

Verve Senior Living operates retirement residences that provide accommodation and care services for seniors. The company focuses on personalized, compassionate support delivered through a team-based approach.

1 investor

Carpe manufactures clinical-grade antiperspirant and skincare products designed to reduce underarm sweat and odor for consumers. The company offers a regimen-based approach with multiple product formulations developed with dermatologist input.

1 investor

CARPL.ai operates a marketplace and enterprise imaging platform for radiology AI, offering over 140 AI applications along with PACS-native orchestration tools that let health systems and radiologists access, evaluate, and deploy AI solutions in their clinical workflows. It serves hospitals and health systems and partners with imaging software vendors such as Intelerad, PaxeraHealth, and DeepHealth.

1 investor

Carpo Novum manufactures biodegradable anastomotic ring systems for surgical bowel resection and reconnection procedures in colorectal surgery. The products are designed to simplify minimally invasive intestinal anastomosis while automatically evacuating from the body within 8-12 days.

1 investor

Carradale Futures develops technology focused on healthcare, having run a hackathon themed around bridging gaps in modern healthcare. The company positions itself as a partner to help organizations improve their operations and processes.

1 investor

Cartessa Aesthetics sources and distributes aesthetic medical devices from leading global manufacturers to dermatologists, plastic surgeons, and medical spas in the U.S. and Canada. The company vets devices based on clinical efficacy, patient experience, and return on investment, positioning itself as an alternative to traditional aesthetic device distributors.

1 investor

Carthera develops SonoCloud®, an implantable ultrasound device that temporarily disrupts the blood-brain barrier to improve drug delivery to the brain for treatment of brain diseases including glioblastoma, brain metastases, and Alzheimer's Disease. The company's technology uses low-intensity pulsed ultrasound combined with microbubbles to increase therapeutic efficacy of existing and new therapies.

1 investor

1 investor

1 investor

Cartwheel delivers evidence-based mental health and clinical care services to students and families through partnerships with school districts. The company uses technology to support schools in providing efficient, organized care to their communities.

1 investor

CARUS Bio develops gene delivery systems and cell-derived biologics for therapeutic applications. The company operates a healthcare division producing skincare and beverage products, while pursuing research in CAR-mRNA technology and therapeutic drug development.

1 investor

Carvolix is a French MedTech company developing AI-guided mini-robotic technologies to support interventional cardiologists in treating patients with valve dysfunction and stroke. The company aims to expand access to complex cardiac and neurointerventional procedures by augmenting clinicians' capabilities and reducing treatment gaps worldwide.

1 investor

CaryHealth provides digital therapeutics solutions for patients, manufacturers, health plans, and healthcare providers. The company was founded by pharmacists and technologists to address healthcare needs.

1 investor

KnippeRx is a licensed, nationwide home delivery and specialty pharmacy that fills prescriptions and delivers medications to patients, with order tracking via text, email, and a mobile app. It integrates with EMR and e-prescribing platforms and connects with telehealth, patient access, and copay assistance providers to serve patients, prescribers, and manufacturer partners.

1 investor

Pfizer is a pharmaceutical company that develops medicines across multiple therapeutic areas through extensive clinical research and testing. It serves patients globally with prescription medications and provides patient assistance programs to improve access to healthcare.

1 investor

Casechek provides a cloud-based platform that automates the implant supply chain and vendor-supported surgical case workflows for hospitals, from procurement to payment. Its tools include EHR-integrated case and vendor management, real-time tray tracking, and an automated bill-only reconciliation and PO solution for perioperative, supply chain, and central sterile processing teams.

1 investor

CaseWorthy provides data and software solutions to health and human service organizations to improve service delivery and outcomes for vulnerable populations. The platform serves nonprofit and government agencies managing cases and support for families and individuals.

1 investor

CASI Pharmaceuticals is a biopharmaceutical company developing CID-103, an investigational anti-CD38 monoclonal antibody targeting B memory, plasmablasts, and plasma cells. It focuses on treatments for antibody-mediated organ transplant rejection and autoimmune diseases such as immune thrombocytopenia.

1 investor

Casira builds HomeSense, a product that uses off-the-shelf smart home sensors (motion, door, environment, and appliance) to passively monitor aging adults living independently and generate plain-language daily summaries and real-time alerts for family caregivers. It targets aging-in-place care without requiring wearables, cameras, or behavior change from the resident.

1 investor